US/$NMTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About US
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Ticker
$NMTC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
17
ISIN
US64130M2098
Website
US Metrics
BasicAdvanced
$29M
-
-$0.22
0.72
-
Price and volume
Market cap
$29M
Beta
0.72
52-week high
$1.16
52-week low
$0.40
Average daily volume
246K
Financial strength
Current ratio
2.129
Quick ratio
0.93
Long term debt to equity
18.384
Total debt to equity
27.66
Interest coverage (TTM)
-15.49%
Management effectiveness
Return on assets (TTM)
-83.48%
Return on equity (TTM)
-265.18%
Valuation
Price to revenue (TTM)
3.008
Price to book
16.22
Price to tangible book (TTM)
17.07
Price to free cash flow (TTM)
-3.496
Growth
Revenue change (TTM)
54.53%
Earnings per share change (TTM)
-61.14%
3-year revenue growth (CAGR)
213.13%
3-year earnings per share growth (CAGR)
-35.47%
US News
AllArticlesVideos
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
GlobeNewsWire·6 days ago
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
GlobeNewsWire·2 weeks ago
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for US stock?
US (NMTC) has a market cap of $29M as of June 09, 2025.
What is the P/E ratio for US stock?
The price to earnings (P/E) ratio for US (NMTC) stock is 0 as of June 09, 2025.
Does US stock pay dividends?
No, US (NMTC) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next US dividend payment date?
US (NMTC) stock does not pay dividends to its shareholders.
What is the beta indicator for US?
US (NMTC) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.